Fact checked byDrew Amorosi

Read more

September 06, 2024
1 min read
Save

Top in allergy/asthma: Pharma vs. farms; young people unlikely to inform peers of allergy

Fact checked byDrew Amorosi
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In a Healio Expert Submission, Douglas H. Jones, MD, FAAAAI, FACAAI, discussed currently available food allergy treatments and some that are in development.

He also posed the question, “Do we need more pharma or farms?”

Farmer pulling sprayer_243850982
The overwhelming majority of oral immunotherapy is derived from food and not pharmaceuticals, Jones observed. Image: Adobe Stock

“In my opinion, among the pharmaceuticals, the biologics can play the most significant role,” Jones said. “However, when looking at food-specific pharmaceutical products, when compared with what we can do with correct usage of food, we need more farms, I think. But I leave that to you to decide.”

It was the top story in allergy/asthma last week.

In another top story, a study revealed that adolescents and young adults felt more comfortable managing their food allergy when with their family than with their friends.

Read these and more top stories in allergy/asthma below:

Do we need more pharma or more farms to treat food allergies?

In the latest installment of Healio’s “Food Allergy: Fact vs. Fiction,” Douglas H. Jones, MD, FAAAAI, FACAAI, reviews state-of-the-art clinical practice for treatment of food allergies. Jones also previews the treatment development pipeline and closes by considering the power of food over medicine. Read more.

Young people feel uneasy managing their allergy around peers, prefer family

Adolescents and young adults reported being less comfortable managing their allergy around their peers than with their families, according to a study published in The Journal of Allergy and Clinical Immunology. Read more.

VIDEO: Updated anaphylaxis parameters expand definition of who is at risk

Recently updated practice parameters will help clinicians better recognize and treat anaphylaxis, Jeffrey Demain, MD, FAAAAI, FACAAI, FAAP, told Healio at the Allergy, Asthma & Immunology CME Conference. Watch here.

Thin film barrier more effective in seasonal allergic rhinitis than saline nasal spray

AM-301 nasal spray was significantly more effective than saline nasal spray in relieving symptoms and improving health-related quality of life among patients with seasonal allergic rhinitis, according to a study published by Allergy. Read more.

San Antonio stroll identifies characteristics of common allergenic trees

Tricia Sowers, PhD, introduced attendees to allergenic trees along the River Walk and discussed how immunotherapy can address them at the Allergy, Asthma & Immunology CME Conference. Read more.